CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
| ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
| Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
| RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
| TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
| EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
| JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
| Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
| First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |